A European research team performed an umbrella systematic review to evaluate how insomnia relates to a range of long-term health outcomes, with particular attention to neurological, psychiatric, and general health endpoints. The review was published in Sleep Medicine Reviews. The authors combined evidence from existing reviews and conducted new systematic reviews and meta-analyses for outcomes lacking pooled estimates, including stroke, workplace injuries, and hospital admissions.
The investigators searched MEDLINE and EMBASE for reviews that examined links between insomnia and outcomes such as dementia, stroke, depression, and suicide-related events. Where prior reviews lacked meta-analyses for important outcomes, the team performed new systematic reviews and pooled analyses. For the stroke outcome they identified nine primary studies representing more than 1.3 million participants and included six of those studies in a meta-analysis. They also located three studies addressing hospital admissions and assessed those together.
The review approach aimed to synthesize available evidence across multiple health domains, while noting differences in study definitions and measurements of sleep problems across the literature.
In pooled analyses, people with insomnia had a 26% higher relative hazard of stroke compared with people without insomnia. The authors caution that this is a relative-risk comparison and does not imply that 26% of people with insomnia will experience a stroke. Separate pooled results for hospital admissions showed 28% higher odds of admission for any reason among people with insomnia.
These findings indicate an association between insomnia and increased risk for both cerebrovascular events and general hospital utilization in the studies included. The review does not attribute causality but highlights an observable correlation across included cohorts and analyses.
Beyond stroke and admission risk, the review identified associations between insomnia and several other outcomes. These included links with dementia, depression, and suicide-related outcomes. The authors did not find an association between insomnia and mortality in the evidence they reviewed. For workplace injuries, the review found only two studies and could not combine their results into a meta-analysis, preventing firm conclusions for that outcome.
The authors explicitly stated that their findings do not prove that insomnia causes the linked conditions. Several limitations in the underlying literature may affect interpretation:
Because of these limitations, the review frames insomnia as a potential marker of elevated health risk rather than as a proven causal factor.
The review authors recommend that clinicians ask about insomnia during neurological and mental health evaluations. Two experts quoted in the source article not involved in the review emphasized clinical implications:
A vascular surgeon noted that chronic insomnia may represent an important marker of long-term cardiovascular health and described plausible mechanisms such as persistent hyperarousal, higher blood pressure, inflammation, arterial stiffness, and endothelial dysfunction.
A public health professor highlighted that the reported 1.26-times higher relative risk for stroke is a comparison between people with and without insomnia and that absolute risk will vary by individual. He also urged better measurement of sleep problems and recommended that chronic insomnia be used as an opportunity for comprehensive cardiovascular and metabolic screening and management.
These expert comments align with the review’s suggestion that insomnia should prompt broader health assessment rather than being dismissed as solely a sleep problem.
The umbrella review found consistent associations between insomnia and higher risks of stroke and hospital admission, and additional links with dementia, depression, and suicide-related outcomes. However, the evidence does not establish causation, and heterogeneity in insomnia definitions and measurement limits interpretation. The review supports asking about sleep symptoms in clinical assessments and integrating evaluation of cardiovascular and metabolic risk factors when chronic insomnia is present. The authors and external experts call for improved, standardized measures of sleep and for clinicians to consider insomnia as a potential clinical signal for broader health risk assessment.